Zepp Health [ZEPP] vs Turtle Beach [TBCH] Detailed Stock Comparison
Zepp Health
NYSE
Loading...
Turtle Beach
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Zepp Health wins in 9 metrics, Turtle Beach wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Zepp Health | Turtle Beach | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -5.31 | 19.35 | Zepp Health |
| Price-to-Book Ratio | 1.57 | 2.35 | Zepp Health |
| Debt-to-Equity Ratio | 47.49 | 49.80 | Zepp Health |
| PEG Ratio | -2,239.00 | -0.11 | Zepp Health |
| EV/EBITDA | -105.68 | 6.89 | Zepp Health |
| Profit Margin (TTM) | -38.81% | 4.03% | Turtle Beach |
| Operating Margin (TTM) | -10.27% | -2.03% | Turtle Beach |
| Return on Equity | -28.32% | 12.49% | Turtle Beach |
| Return on Assets (TTM) | -5.10% | 8.87% | Turtle Beach |
| Free Cash Flow (TTM) | $-25.88M | $847,000 | Turtle Beach |
| 1-Year Return | 870.70% | 6.16% | Zepp Health |
| Price-to-Sales Ratio (TTM) | 1.61 | 0.76 | Turtle Beach |
| Enterprise Value | $4.47B | $337.01M | Zepp Health |
| EV/Revenue Ratio | 22.34 | 0.89 | Turtle Beach |
| Gross Profit Margin (TTM) | 37.27% | 36.57% | Zepp Health |
| Revenue per Share (TTM) | $12 | $19 | Turtle Beach |
| Earnings per Share (Diluted) | $-4.80 | $0.74 | Turtle Beach |
| Beta (Stock Volatility) | 1.12 | 1.97 | Zepp Health |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Zepp Health vs Turtle Beach Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Zepp Health | 2.26% | 91.15% | 385.35% | 834.21% | 771.93% | 765.85% |
| Turtle Beach | 8.81% | 12.00% | 12.40% | 59.35% | -11.76% | -8.04% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Zepp Health | 870.70% | 204.53% | -57.45% | -45.41% | -45.41% | -45.41% |
| Turtle Beach | 6.16% | 48.77% | -8.84% | 74.22% | 124.00% | 124.00% |
Performance & Financial Health Analysis: Zepp Health vs Turtle Beach
| Metric | ZEPP | TBCH |
|---|---|---|
| Market Information | ||
| Market Cap | $321.70M | $288.50M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 333,011 | 220,700 |
| 90 Day Avg. Volume | 1,044,594 | 235,933 |
| Last Close | $24.85 | $15.68 |
| 52 Week Range | $2.12 - $27.86 | $8.78 - $19.50 |
| % from 52W High | -10.80% | -19.59% |
| All-Time High | $81.00 (Feb 15, 2021) | $89.55 (May 13, 2013) |
| % from All-Time High | -69.32% | -82.49% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.46% | 0.14% |
| Quarterly Earnings Growth | 5.89% | 0.14% |
| Financial Health | ||
| Profit Margin (TTM) | -0.39% | 0.04% |
| Operating Margin (TTM) | -0.10% | -0.02% |
| Return on Equity (TTM) | -0.28% | 0.12% |
| Debt to Equity (MRQ) | 47.49 | 49.80 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $14.22 | $6.09 |
| Cash per Share (MRQ) | $0.22 | $0.58 |
| Operating Cash Flow (TTM) | $-25,970,000 | $18.96M |
| Levered Free Cash Flow (TTM) | $-134,703,985 | $15.02M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Zepp Health vs Turtle Beach
| Metric | ZEPP | TBCH |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -5.31 | 19.35 |
| Forward P/E | -2,239.00 | 10.38 |
| PEG Ratio | -2,239.00 | -0.11 |
| Price to Sales (TTM) | 1.61 | 0.76 |
| Price to Book (MRQ) | 1.57 | 2.35 |
| Market Capitalization | ||
| Market Capitalization | $321.70M | $288.50M |
| Enterprise Value | $4.47B | $337.01M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 22.34 | 0.89 |
| Enterprise to EBITDA | -105.68 | 6.89 |
| Risk & Other Metrics | ||
| Beta | 1.12 | 1.97 |
| Book Value per Share (MRQ) | $14.22 | $6.09 |
Financial Statements Comparison: Zepp Health vs Turtle Beach
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ZEPP | TBCH |
|---|---|---|
| Revenue/Sales | $38.54M | $63.90M |
| Cost of Goods Sold | $24.18M | $40.53M |
| Gross Profit | $14.36M | $23.37M |
| Research & Development | $12.38M | $3.99M |
| Operating Income (EBIT) | $-18.38M | $-1.30M |
| EBITDA | $-17.79M | $1.53M |
| Pre-Tax Income | $-19.27M | $-773,000 |
| Income Tax | $110,000 | $-109,000 |
| Net Income (Profit) | $-19.74M | $-664,000 |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ZEPP | TBCH |
|---|---|---|
| Cash & Equivalents | $76.43M | $11.68M |
| Total Current Assets | $242.46M | $142.24M |
| Total Current Liabilities | $212.34M | $72.43M |
| Long-Term Debt | $71.16M | $45.54M |
| Total Shareholders Equity | $232.04M | $120.87M |
| Retained Earnings | $8.88M | $-118.76M |
| Property, Plant & Equipment | $9.56M | $17.26M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ZEPP | TBCH |
|---|---|---|
| Operating Cash Flow | $-14.63M | $42.97M |
| Capital Expenditures | $-2.92M | $-166,000 |
| Free Cash Flow | $-16.89M | $40.29M |
| Debt Repayment | N/A | $-108.41M |
| Common Stock Repurchase | N/A | $-1.75M |
Short Interest & Institutional Ownership Analysis
| Metric | ZEPP | TBCH |
|---|---|---|
| Shares Short | 308,546 | 2.77M |
| Short Ratio | 0.25 | 10.71 |
| Short % of Float | 0.05% | 0.17% |
| Average Daily Volume (10 Day) | 333,011 | 220,700 |
| Average Daily Volume (90 Day) | 1,044,594 | 235,933 |
| Shares Outstanding | 231.98M | 19.96M |
| Float Shares | 108.71M | 11.13M |
| % Held by Insiders | 0.06% | 0.29% |
| % Held by Institutions | 0.26% | 0.60% |
Dividend Analysis & Yield Comparison: Zepp Health vs Turtle Beach
| Metric | ZEPP | TBCH |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | $0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |